Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

PU.1 and Haematopoietic Cell Fate: Dosage Matters.

Mak KS, Funnell AP, Pearson RC, Crossley M.

Int J Cell Biol. 2011;2011:808524. doi: 10.1155/2011/808524. Epub 2011 Aug 10.

2.

PU.1 and partners: regulation of haematopoietic stem cell fate in normal and malignant haematopoiesis.

Gupta P, Gurudutta GU, Saluja D, Tripathi RP.

J Cell Mol Med. 2009 Nov-Dec;13(11-12):4349-63. doi: 10.1111/j.1582-4934.2009.00757.x. Epub 2009 Apr 6. Review.

3.

M-CSF instructs myeloid lineage fate in single haematopoietic stem cells.

Mossadegh-Keller N, Sarrazin S, Kandalla PK, Espinosa L, Stanley ER, Nutt SL, Moore J, Sieweke MH.

Nature. 2013 May 9;497(7448):239-43. doi: 10.1038/nature12026. Epub 2013 Apr 10.

4.

Is PU.1 a dosage-sensitive regulator of haemopoietic lineage commitment and leukaemogenesis?

Dakic A, Wu L, Nutt SL.

Trends Immunol. 2007 Mar;28(3):108-14. Epub 2007 Jan 30. Review.

PMID:
17267285
5.

Stem cell fate specification: role of master regulatory switch transcription factor PU.1 in differential hematopoiesis.

Gangenahalli GU, Gupta P, Saluja D, Verma YK, Kishore V, Chandra R, Sharma RK, Ravindranath T.

Stem Cells Dev. 2005 Apr;14(2):140-52. Review.

PMID:
15910240
6.

Precise developmental regulation of Ets family transcription factors during specification and commitment to the T cell lineage.

Anderson MK, Hernandez-Hoyos G, Diamond RA, Rothenberg EV.

Development. 1999 Jun;126(14):3131-48.

7.

Lineage switch induced by overexpression of Ets family transcription factor PU.1 in murine erythroleukemia cells.

Yamada T, Abe M, Higashi T, Yamamoto H, Kihara-Negishi F, Sakurai T, Shirai T, Oikawa T.

Blood. 2001 Apr 15;97(8):2300-7.

8.

Osteopetrosis in mice lacking haematopoietic transcription factor PU.1.

Tondravi MM, McKercher SR, Anderson K, Erdmann JM, Quiroz M, Maki R, Teitelbaum SL.

Nature. 1997 Mar 6;386(6620):81-4.

PMID:
9052784
9.

The importance of PU.1 concentration in hematopoietic lineage commitment and maturation.

Dahl R, Simon MC.

Blood Cells Mol Dis. 2003 Sep-Oct;31(2):229-33. Review.

PMID:
12972030
10.

Cloche is a bHLH-PAS transcription factor that drives haemato-vascular specification.

Reischauer S, Stone OA, Villasenor A, Chi N, Jin SW, Martin M, Lee MT, Fukuda N, Marass M, Witty A, Fiddes I, Kuo T, Chung WS, Salek S, Lerrigo R, Alsiö J, Luo S, Tworus D, Augustine SM, Mucenieks S, Nystedt B, Giraldez AJ, Schroth GP, Andersson O, Stainier DY.

Nature. 2016 Jul 14;535(7611):294-8. doi: 10.1038/nature18614.

PMID:
27411634
11.

Transient expression of PU.1 commits multipotent progenitors to a myeloid fate whereas continued expression favors macrophage over granulocyte differentiation.

McIvor Z, Hein S, Fiegler H, Schroeder T, Stocking C, Just U, Cross M.

Exp Hematol. 2003 Jan;31(1):39-47.

PMID:
12543105
12.
13.

HoxA3 is an apical regulator of haemogenic endothelium.

Iacovino M, Chong D, Szatmari I, Hartweck L, Rux D, Caprioli A, Cleaver O, Kyba M.

Nat Cell Biol. 2011 Jan;13(1):72-8. doi: 10.1038/ncb2137. Epub 2010 Dec 19.

14.

Role of PU.1 in hematopoiesis.

Fisher RC, Scott EW.

Stem Cells. 1998;16(1):25-37. Review.

15.

Thrombopoietin-induced expression of the glycoprotein IIb gene involves the transcription factor PU.1/Spi-1 in UT7-Mpl cells.

Doubeikovski A, Uzan G, Doubeikovski Z, Prandini MH, Porteu F, Gisselbrecht S, Dusanter-Fourt I.

J Biol Chem. 1997 Sep 26;272(39):24300-7.

16.

Spi-1/PU.1 is a positive regulator of the Fli-1 gene involved in inhibition of erythroid differentiation in friend erythroleukemic cell lines.

Starck J, Doubeikovski A, Sarrazin S, Gonnet C, Rao G, Skoultchi A, Godet J, Dusanter-Fourt I, Morle F.

Mol Cell Biol. 1999 Jan;19(1):121-35.

17.

Notch/Delta signaling constrains reengineering of pro-T cells by PU.1.

Franco CB, Scripture-Adams DD, Proekt I, Taghon T, Weiss AH, Yui MA, Adams SL, Diamond RA, Rothenberg EV.

Proc Natl Acad Sci U S A. 2006 Aug 8;103(32):11993-8. Epub 2006 Jul 31. Erratum in: Proc Natl Acad Sci U S A. 2006 Sep 19;103(38):14255.

18.

Runx1 regulates embryonic myeloid fate choice in zebrafish through a negative feedback loop inhibiting Pu.1 expression.

Jin H, Li L, Xu J, Zhen F, Zhu L, Liu PP, Zhang M, Zhang W, Wen Z.

Blood. 2012 May 31;119(22):5239-49. doi: 10.1182/blood-2011-12-398362. Epub 2012 Apr 4.

19.

PU.1 and NFATc1 mediate osteoclastic induction of the mouse beta3 integrin promoter.

Crotti TN, Sharma SM, Fleming JD, Flannery MR, Ostrowski MC, Goldring SR, McHugh KP.

J Cell Physiol. 2008 Jun;215(3):636-44. doi: 10.1002/jcp.21344.

PMID:
18288635
20.

The hematopoietic transcription factor PU.1 is downregulated in human multiple myeloma cell lines.

Pettersson M, Sundström C, Nilsson K, Larsson LG.

Blood. 1995 Oct 1;86(7):2747-53.

Supplemental Content

Support Center